1278424

Hummayun Ismail, M.D. — FEI 3038166848

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 1, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Newark, DE (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance